United States · FDA National Drug Code directory
triamcinolone acetonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-817_a43dca71-a425-4ce0-a84d-d2586b77a978
- Product NDC
- 45802-817
- Form
- OINTMENT
- Composition / generic term
- triamcinolone acetonide
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210301
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAMCINOLONE ACETONIDE — .5 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 430 g in 1 JAR (45802-817-01) · 45802-817-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →